FDA Grants Moderna's, COVID-19 Vaccine , Full Approval.
On January 31, Moderna announced that its COVID-19 vaccine has been granted full approval by United States health regulators.
.
On January 31, Moderna announced that its COVID-19 vaccine has been granted full approval by United States health regulators.
.
The Associated Press reports that since its emergency authorization over a year ago, the vaccine has already been given to tens of millions of Americans.
.
The Associated Press reports that since its emergency authorization over a year ago, the vaccine has already been given to tens of millions of Americans.
.
In August of 2021, the FDA granted full approval to Pfizer's vaccine.
The Associated Press reports that over 211 million Americans are fully vaccinated - about 63% of the population.
.
The Associated Press reports that over 211 million Americans are fully vaccinated - about 63% of the population.
.
Approximately 86 million people have received at least one dose of a booster.
.
According to the AP, vaccinations peaked at over 3 million doses were distributed per day last spring.
Now, daily doses average less than 750,000.
.
The AP reports that the vaccine's initial emergency approval was based on a study that tracked 44,000 people for two months.
Moderna then continued that study to complete longer six-month-long studies normally required for full approval.
.
The FDA reportedly monitored for serious side effects that have proven to be extremely rare.
.
The FDA reportedly monitored for serious side effects that have proven to be extremely rare.
.
Last fall, the FDA delayed approving Moderna's vaccine for use in 12 to 17 year olds as it investigated the risk of heart inflammation in young men.
.
Last fall, the FDA delayed approving Moderna's vaccine for use in 12 to 17 year olds as it investigated the risk of heart inflammation in young men.
